Neuroscience22 December 2025

Valproic Acid and Autism: Unlocking the Link Between Epilepsy Drugs and Brain Development

Source Publication

Primary AuthorsRodrigues, Silva, Andreotti et al.

Visualisation for: Valproic Acid and Autism: Unlocking the Link Between Epilepsy Drugs and Brain Development
Visualisation generated via Synaptic Core
Doctors have known for some time that managing epilepsy during pregnancy requires a delicate balance. If a mother takes certain medications to control seizures, there is a chance it might affect how her baby’s brain wires itself. A recent laboratory study using mice has shed fresh light on the biological machinery behind the link between **Valproic Acid and Autism**.

How Valproic Acid and Autism are Linked in the Lab

To understand this connection, researchers injected pregnant mice with valproic acid (VPA). They then waited for the male offspring to grow up. If the drug changed brain development, then the mice should act differently from those born to untreated mothers.

The results were stark. The mice exposed to VPA displayed high levels of anxiety. They avoided other mice. They struggled to learn from negative experiences. These behaviours mirror the social and sensory challenges often seen in humans on the autism spectrum.

A Surprise in the Frontal Cortex

The team didn't just watch the mice; they looked inside their brains. They measured specific proteins in the frontal cortex, the area responsible for complex thinking and personality.

They found two major changes:

  • PSD-95: A marker for synaptic connection. Levels were unusually high, suggesting the brain was 'over-connected' or too excitable.
  • Klotho: A protein usually associated with anti-ageing.

This is where it gets interesting. The study measured a significant spike in Klotho levels in the frontal cortex, though not in the hippocampus or cerebellum.

What Does This Mean?

The presence of extra Klotho is a puzzle. It suggests the brain might be trying to protect itself from the initial damage caused by the drug. Alternatively, the excess protein could be contributing to the problem. If Klotho is acting as a shield, it could become a target for future treatments. However, because this was an animal study, we cannot yet say for certain if the same chemical spikes happen in humans. It simply points us toward where to look next.

Cite this Article (Harvard Style)

Rodrigues et al. (2025). 'Valproic Acid and Autism: Unlocking the Link Between Epilepsy Drugs and Brain Development'. Source Journal. Available at: https://doi.org/10.21203/rs.3.rs-7990024/v1

Source Transparency

This intelligence brief was synthesised by The Synaptic Report's autonomous pipeline. While every effort is made to ensure accuracy, professional due diligence requires verifying the primary source material.

Verify Primary Source
EpilepsyRole of Klotho protein in autism spectrum disorderSynaptic plasticity markers in autism researchEffects of gestational valproic acid exposure